Jenny S. Guadamuz, PhD, MSPH

Assistant Professor
Health Policy & Management

Jenny S. Guadamuz is an Assistant Professor at the UC Berkeley School of Public Health, Division of Health Policy and Management. As a health services researcher and pharmacoepidemiologist, Dr. Guadamuz uses an interdisciplinary approach to identify how structural determinants impact the use of healthcare, especially medications among minoritized racial/ethnic populations. Her current research focuses on health inequities across immigration status. Immigration status is a critical yet overlooked factor influencing inequities because noncitizens endure significant barriers to legal and social protections, including systemic exclusions from healthcare. She also conducts research in the fields of drug utilization among historically excluded populations, federal policies to mitigate drug risks, and the role of pharmacy accessibility in determining access to medications using electronic health records, administrative claims, surveys, and geospatial data. Her unique research perspective has garnered funding from the Robert Wood Johnson Foundation, as part of their inaugural cohort of Health Policy Research Scholars. Her research appears in several high-impact journals, including JAMA, Health Affairs, and the American Journal of Public Health.

Jenny S. Guadamuz is an Assistant Professor at the UC Berkeley School of Public Health, Division of Health Policy and Management. She is a member of the Latinx and Democracy Faculty Cluster.

Dr. Guadamuz is a health services researcher and pharmacoepidemiologist who uses an interdisciplinary approach to identify how structural determinants impact healthcare access, especially medications among minoritized racial/ethnic populations. Her current research focuses on health inequities across immigration status. Immigration status is a critical yet overlooked factor influencing disparities because noncitizens endure significant barriers to legal and social protections, including systemic exclusions from healthcare.

She also conducts research in the fields of drug utilization among historically excluded populations (e.g., racial/ethnic inequities in clinical trial participation), federal policies to mitigate drug risks, and the role of pharmacy accessibility in determining access to medications using electronic health records, administrative claims, surveys, and geospatial data.

Dr. Guadamuz’s research has been published in high-impact, peer-reviewed journals, including JAMA, the American Journal of Public Health, and Health Affairs. Her unique research perspective has garnered funding from the Robert Wood Johnson Foundation, as part of their inaugural cohort of Health Policy Research Scholars, and the National Heart, Lung, and Blood Institute, as a T32 fellow.

Prior to joining UC Berkeley, she spent two years in the biotech industry, leading research to inform efforts to reduce inequities in cancer care and outcomes. Dr. Guadamuz completed her postdoctoral training at the University of Southern California and completed her PhD in pharmacoepidemiology and pharmaceutical policy at the University of Illinois Chicago (UIC). She also holds an MS in health policy and administration from UIC and a BA in economics from Saint Louis University.

  • Postdoctoral Fellow, University of Southern California
  • PhD, University of Illinois Chicago
  • MS, University of Illinois Chicago
  • BA, Saint Louis University
  • Immigrant health
  • Inequities in chronic disease prevention and management
  • Structural racism and healthcare inequities
  • Access to essential medicines